VitalRhythm vs EchoNext
AI Verdict
Choose VitalRhythm if…
Choose VitalRhythm if you need a continuous, wearable remote patient monitoring solution to detect and analyze transient cardiac arrhythmias over an extended period. It is ideal for clinicians who want to integrate patch-based biosensors with cloud-based AI to track real-time ECG signals and capture events like atrial fibrillation or ventricular tachycardia outside the clinic.
View VitalRhythm →Choose EchoNext if…
Choose EchoNext if you want to screen for hidden structural heart diseases, such as heart failure or valve disease, using standard, non-invasive 12-lead ECGs. It is best suited for providers looking for a point-of-care clinical decision support tool to identify structural risks during routine diagnostic workups without requiring continuous wearable monitoring.
View EchoNext →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | VitalRhythm | EchoNext |
|---|---|---|
| Pricing | Contact for quote | Starts at $600/month |
| Deployment | Cloud-based | Available through the OpenEvidence clinical decision support platform. |
| BAA Available | Yes AI-estimated | Yes AI-estimated |
| FDA Status | Yes AI-estimated | Yes AI-estimated |
| HIPAA | Yes AI-estimated | Yes AI-estimated |
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | VitalRhythm | EchoNext |
|---|---|---|
| Company | VitalConnect | Pathway Labs |
| Tagline | Leader in wearable biosensor technology for wireless patient monitoring | How's your heart? |
| Target Size | Not specified | EchoNext is designed for broad access, from major hospitals to community practices. |
| Headquarters | Not specified | New York, USA |
| Primary Input Data Source | Continuous ECG signal analysis via VitalPatch biosensor | Standard 12-lead ECGs |
Videos
Demos, reviews, and walkthroughs featuring VitalRhythm and EchoNext.